Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone for Depressive Mixed State
NCT00490542Phase 2Completed
- Sponsor
- Tufts Medical Center
- Start
- Dec 2006
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Bipolar II disorder (BP-II) and major depressive disorder (MDD) comparing Geodon Arm with Placebo Arm (2 arms). Primary endpoint: Montgomery-Asberg Depression Rating Scale at 6 weeks. Started Dec 2006; status: completed.
02
Drugs
ziprasidone
03
Conditions
Bipolar II disorder (BP-II)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00490542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490542.